| 1.21 -0.04 (-3.2%) | 01-26 16:00 | |||||||||||||
|
|
| Short term | ||||
| Mid term | |
|||
| Targets | 6-month : | 1.56 | 1-year : | 1.82 |
| Resists | First : | 1.34 | Second : | 1.56 |
| Pivot price | 1.24 |
|||
| Supports | First : | 1.17 | Second : | 1.07 |
| MAs | MA(5) : | 1.23 |
MA(20) : | 1.22 |
| MA(100) : | 1.5 |
MA(250) : | 1.51 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 61.5 |
D(3) : | 65.1 |
| RSI | RSI(14): 45.4 |
|||
| 52-week | High : | 3.09 | Low : | 0.94 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ QSI ] has closed above bottom band by 19.8%. Bollinger Bands are 79.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 36 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 1.27 - 1.28 | 1.28 - 1.29 |
| Low: | 1.19 - 1.2 | 1.2 - 1.21 |
| Close: | 1.2 - 1.21 | 1.21 - 1.22 |
Quantum-Si incorporated, a life sciences company, develops a single molecule detection platform for sample preparation and sequencing. It offers a proprietary single molecule detection platform for use in semiconductor industry to field proteomics to enable next generation protein sequencing. The company was incorporated in 2013 is based in Guilford, Connecticut.
Tue, 13 Jan 2026
Quantum-Si (NASDAQ:QSI) Shares Down 0.8% - Should You Sell? - MarketBeat
Fri, 09 Jan 2026
Quantum-Si (NASDAQ:QSI) adds US$32m to market cap in the past 7 days, though investors from five years ago are still down 88% - Sahm
Fri, 09 Jan 2026
Quantum-Si (NASDAQ:QSI) adds US$32m to market cap in the past 7 days, though investors from five years ago are still down 88% - simplywall.st
Mon, 05 Jan 2026
Quantum-Si (NASDAQ:QSI) shareholders have endured a 89% loss from investing in the stock five years ago - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 0 (M) |
| Shares Float | 196 (M) |
| Held by Insiders | 1.7785e+008 (%) |
| Held by Institutions | 11.6 (%) |
| Shares Short | 18,840 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -1.0236e+008 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -4 % |
| Return on Assets (ttm) | 419.5 % |
| Return on Equity (ttm) | -26.9 % |
| Qtrly Rev. Growth | 3.18e+006 % |
| Gross Profit (p.s.) | -9.87 |
| Sales Per Share | -17.31 |
| EBITDA (p.s.) | 541254 |
| Qtrly Earnings Growth | -0.7 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -101 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.07 |
| Price to Cash Flow | 3.36 |
| Dividend | 0 |
| Forward Dividend | 1.926e+007 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |